Uncategorized Alterome Therapeutics Strengthens Leadership Team with Appointment of Renowned Oncologist Dr. Andrew S. Chi as Chief Medical Officer August 23, 2023 Alterome Therapeutics, Inc., a frontrunner in precision oncology, has… BioTech Health XAugust 23, 2023 0 Shares 0 0 0 0 0 0 0
BioTech CEO InterviewsExclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future Jak ThomsonJuly 14, 2023
Biotech NewsRecent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data BioTech Health XMay 9, 2023
UncategorizedAlterome Therapeutics Strengthens Leadership Team with Appointment of Renowned Oncologist Dr. Andrew S. Chi as Chief Medical Officer BioTech Health XAugust 23, 2023
BioTech CEO InterviewsExclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future Jak ThomsonJuly 14, 2023
Biotech NewsRecent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data BioTech Health XMay 9, 2023
UncategorizedAlterome Therapeutics Strengthens Leadership Team with Appointment of Renowned Oncologist Dr. Andrew S. Chi as Chief Medical Officer BioTech Health XAugust 23, 2023 August 23, 2023 Alterome Therapeutics, Inc., a frontrunner in precision oncology, has announced the addition of Dr. Andrew… Read More 0 Shares 0 0 0 0 0 0 0
BioTech CEO InterviewsExclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future Jak ThomsonJuly 14, 2023 About Cel-Sci Corporation Cel-Sci Corporation is a publicly traded biotechnology business which develops, manufactures, and markets treatments focused… Read More 0 Shares 0 0 0 0 0 0 0
Uncategorized11/19/21 BioTech Health XMay 30, 2023 BioTech Health X Ortho Clinical Diagnostics Overview & Q&A Michael S. Iskra, Executive Vice President of Commercial Excellence… Read More 0 Shares 0 0 0 0 0 0 0
Biotech NewsWelcome To BioTech Health X BioTech Health XMay 26, 2023 The New Leader in BioTech News, BioTech Stock Information & BioTech Industry Analysis BioTech Health X delivers the… Read More 0 Shares 0 0 0 0 0 0 0
Biotech NewsRecent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data BioTech Health XMay 9, 2023 A recent report published by the American Association for Cancer Research titled Subgroup Analyses in Oncology Trials: Regulatory… Read More 0 Shares 0 0 0 0 0 0 0
Biotech NewsVirios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results BioTech Health XSeptember 19, 2022 In a shocking failure, Virios Therapeutics announced this morning pre-market that topline results from its FORTRESS (Fibromyalgia Outcome… Read More 1 Shares 1 0 0 0 0 0 0
Biotech NewsCEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022 BioTech Health XSeptember 10, 2022 CEL-SCI recently presented its Phase 3 data at ESMO 2022, which revealed that Neoadjuvant Multikine achieved groundbreaking tumor… Read More 21 Shares 21 0 0 0 0 0 0
Biotech NewsMayo Clinic, Hibiscus BioVentures, and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator BioTech Health XAugust 31, 2022 Mayo Clinic, Hibiscus BioVentures (Hibiscus), and Innoforce have announced the formation of Mayflower BioVentures, a cell and gene… Read More 0 Shares 0 0 0 0 0 0 0
Biotech NewsKrystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial BioTech Health XAugust 1, 2022 Leader in redosable gene therapy Krystal Biotech, Inc. (NASDAQ: KRYS) announced today the United States Food and Drug… Read More 0 Shares 0 0 0 0 0 0 0
Biotech NewsImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug BioTech Health XJuly 28, 2022 In breaking news, clinical-stage biotechnology company ImmunityBio, Inc. (NASDAQ: IBRX) has announced acceptance by the FDA review of… Read More 0 Shares 0 0 0 0 0 0 0
Biotech NewsBrickell Biotech Regains Nasdaq Compliance Meeting Minimum Bid Price Requirement BioTech Health XJuly 20, 2022 Clinical-stage pharmaceutical company Brickell Biotech, Inc. (Nasdaq: BBI) announced that the company has received formal notice from The… Read More 0 Shares 0 0 0 0 0 0 0
Biotech NewsMerck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial BioTech Health XJuly 20, 2022 Today Merck & Co. (NYSE: MRK) announced that Keytruda has failed the Phase 3 clinical trial KEYNOTE-412 evaluating… Read More 0 Shares 0 0 0 0 0 0 0
Biotech InfoWhat is Biotechnology: Types, Examples and Applications BioTech Health XJune 24, 2022 Understanding biotechnology Biotech involves studying organism functions at the molecular level and is often combined with many different… Read More 0 Shares 0 0 0 0 0 0 0
Biotech NewsOcugen Announces FDA Clinical Hold Removal for Phase 2/3 COVAXIN (BBV152) Clinical Trial BioTech Health XMay 23, 2022 Biotechnology company Ocugen, Inc. (NASDAQ: OCGN) announced today that the U.S. Food and Drug Administration (FDA) has removed… Read More 0 Shares 0 0 0 0 0 0 0
Biotech NewsBenchSci Expands Advisory Board with New Pharma R&D Leaders Jak ThomsonApril 21, 2022 BenchSci has welcomed three new members to its advisory board from the pharmacology sector. Steve Hitchcock of Takeda… Read More 0 Shares 0 0 0 0 0 0 0
Biotech NewsEF Hutton Initiates Coverage of Cel-Sci (CVM) with $17 Price Target Ahead of Rumored News BioTech Health XApril 7, 2022 Tim Moore, CFA an Analyst at EF Hutton has recently published a report citing the opportunities for growth… Read More 0 Shares 0 0 0 0 0 0 0
Biotech NewsLegend Biotech Appoints Dr. Guowei Fang As Head of Global Research and Early Development BioTech Health XApril 1, 2022 Global biotechnology company Legend Biotech Corporation (NASDAQ: LEGN) announced today that Guowei Fang, Ph.D. will take over as… Read More 0 Shares 0 0 0 0 0 0 0
Biotech News2seventy bio Secure $170 Million Extending Cash Runway Into 2025 BioTech Health XMarch 16, 2022 2seventy bio (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, today announced that it has agreed to sell… Read More 0 Shares 0 0 0 0 0 0 0